908 Devices Stock (NASDAQ:MASS)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$6.26

52W Range

$3.55 - $9.34

50D Avg

$6.26

200D Avg

$6.68

Market Cap

$217.52M

Avg Vol (3M)

$402.80K

Beta

0.49

Div Yield

-

MASS Company Profile


908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

246

IPO Date

Dec 18, 2020

Website

MASS Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Product and service revenue$6.99M$59.63M$49.86M
Device Sales$36.66M$35.99M$33.38M
Recurring$19.42M$23.32M$16.48M
Contract$117.00K$317.00K$370.00K

Fiscal year ends in Dec 25 | Currency in USD

MASS Financial Summary


Dec 25Dec 24Dec 23
Revenue$56.20M$59.63M$50.23M
Operating Income$-39.42M$-76.72M$-42.76M
Net Income$19.49M$-72.21M$-36.40M
EBITDA$-21.50M$-43.88M$-40.27M
Basic EPS$0.54$-2.12$-1.13
Diluted EPS$0.54$-2.12$-1.13

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25Mar 03, 26 | 8:30 AM
Q3 25Nov 10, 25 | 8:30 AM
Q2 25Aug 05, 25 | 8:30 AM

Peer Comparison


TickerCompany
SNWVSANUWAVE Health, Inc.
SENSSenseonics Holdings, Inc.
QTRXQuanterix Corporation
CERSCerus Corporation
ACRSAclaris Therapeutics, Inc.
SGHTSight Sciences, Inc.
NNOXNano-X Imaging Ltd.
NPCENeuroPace, Inc.
CAPRCapricor Therapeutics, Inc.
CVRXCVRx, Inc.